v3.26.1
NET LOSS PER SHARE
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
NET LOSS PER SHARE

11. NET LOSS PER SHARE

Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock of the Company outstanding during the period. Diluted net loss per share is computed by giving effect to all common equivalent shares of the Company, including outstanding stock options, RSUs, and warrants to the extent dilutive. Basic and diluted net loss per share was the same for each period presented as the inclusion of all common equivalent shares of the Company outstanding would have been anti-dilutive.

The following table presents the calculation of basic and diluted net loss per share for the Company’s common stock:

 

 

Three Months Ended
March 31,

 

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

Net Loss

 

$

(8,623

)

 

$

(9,418

)

Numerator for Basic and Dilutive EPS – Loss available to common stockholders

 

$

(8,623

)

 

$

(9,418

)

Denominator:

 

 

 

 

 

 

Common Stock

 

 

97,695,133

 

 

 

75,697,199

 

Denominator for Basic and Dilutive EPS - Weighted-average common stock

 

 

97,695,133

 

 

 

75,697,199

 

Basic and dilutive net loss per share

 

$

(0.09

)

 

$

(0.12

)

 

Since the Company was in a net loss position for all periods presented, net loss per share attributable to Class A and Class B common stockholders was the same on a basic and diluted basis, as the inclusion of all common equivalent shares outstanding would have been anti-dilutive. Anti-dilutive common equivalent shares were as follows:

 

 

Three Months Ended
March 31,

 

 

 

2026

 

 

2025

 

Outstanding options to purchase common stock

 

 

15,336,803

 

 

 

17,954,246

 

Outstanding RSUs

 

 

5,707,929

 

 

 

2,441,983

 

Warrants issued in connection with February 2025 Offering

 

 

4,257,419

 

 

 

4,511,178

 

Warrants issued in connection with Loan Agreement

 

 

562,500

 

 

 

 

Total anti-dilutive common equivalent shares

 

 

25,864,651

 

 

 

24,907,407

 

The Loan Agreement also provides for Additional Warrants to purchase up to an aggregate of 520,835 shares of Class A common stock at an exercise price of $1.20 per share, contingent on and exercisable only upon the funding of future term loan tranches under the Loan Agreement. As no additional term loan tranches had been drawn as of March 31, 2026, no shares were issuable under the Additional Warrants as of March 31, 2026, and such Additional Warrants were excluded from the table above.